The insurance moguls Hank and Evan Greenberg both want better engagement with China. The way they argue for it, however, has some telling differences.
Illustration by Luis Grañena
In April 1999, Chinese Premier Zhu Rongji made a visit to Washington, D.C., to meet with President Bill Clinton. A few days earlier, the American president had delivered a speech voicing strong support for China’s admission into the World Trade Organization, a long held priority for Beijing. While acknowledging the Chinese Communist Party’s human rights abuses and other problems, Clinton stressed the hope that economic development would liberalize China.
“Is this a country to be engag
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
At the height of the pandemic, Chinese vaccine maker Sinovac was a hero and one of the country’s most promising companies. But its success masked a protracted dispute between rival investors and management for control of the cash-rich company. The Wire China investigates what went wrong.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
